Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
2.7400
+0.0600
+(2.24%)
At close: February 24 at 4:00:00 PM EST
2.7500
0.00
(0.00%)
After hours: February 24 at 4:05:03 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-17,958
-23,879
-11,812
-7,251
Investing Cash Flow
--
18,682
-89,936
19,273
-7,817
Financing Cash Flow
--
5,297
96,905
111
29,317
End Cash Position
--
12,657
6,686
23,854
16,174
Income Tax Paid Supplemental Data
--
16
8
1
2
Interest Paid Supplemental Data
--
52
--
--
--
Capital Expenditure
--
-6,401
-904
-2,927
-3,767
Issuance of Capital Stock
--
--
--
--
28,726
Issuance of Debt
--
5,248
--
--
--
Free Cash Flow
--
-24,359
-24,783
-14,739
-11,018
12/31/2020 - 3/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NVCT Nuvectis Pharma, Inc.
7.36
-3.03%
ARMP Armata Pharmaceuticals, Inc.
2.0800
-1.19%
TRDA Entrada Therapeutics, Inc.
12.85
-1.46%
MTVA MetaVia Inc.
1.5600
-1.27%
OBIO Orchestra BioMed Holdings, Inc.
4.7800
+1.27%
DSGN Design Therapeutics, Inc.
4.8000
-2.24%
AVIR Atea Pharmaceuticals, Inc.
3.1400
+1.62%
EYPT EyePoint Pharmaceuticals, Inc.
5.91
-3.90%
GYRE Gyre Therapeutics, Inc.
10.55
-8.58%
CSCI COSCIENS Biopharma Inc.
2.8500
+0.71%